📊 MPT Key Takeaways
Is Medical Properties Trust Inc. (MPT) a Good Investment?
Medical Properties Trust faces critical financial distress despite positive net income: negative operating cash flow of -$14.3M combined with $9.7B debt and interest coverage of 0.0x creates unsustainable leverage. The company cannot generate cash from operations to service debt obligations, indicating potential liquidity stress ahead.
Fundamentals are weak: revenue is declining, operating and net income are negative, and interest coverage is -0.5x, indicating earnings do not cover financing costs. High leverage (2.11x D/E, $9.7B long-term debt) magnifies refinancing and covenant risk despite positive operating cash flow. Until operating profitability and coverage improve, balance sheet risk outweighs upside.
Why Buy Medical Properties Trust Inc. Stock? MPT Key Strengths
- Positive net income of $32.8M indicates some profitability despite operational headwinds
- Substantial asset base of $14.8B provides collateral and restructuring options
- EPS grew 88.6% YoY, suggesting earnings recovery from prior period lows
- Positive operating cash flow and 23.7% FCF margin
- Large asset base ($15.0B) with $4.61B equity
- Cash on hand of $540.86M provides some liquidity
MPT Stock Risks: Medical Properties Trust Inc. Investment Risks
- Negative operating cash flow (-$14.3M) and negative free cash flow (-$14.3M) signal operational cash generation failure, critical for REIT viability
- Interest coverage ratio of 0.0x means operating income cannot cover debt service; company depends on non-operating income or asset sales
- High debt-to-equity ratio of 2.13x combined with negative cash flow creates severe refinancing and liquidity risk
- Revenue declining 2.4% YoY with extremely thin 0.1% operating margin indicates operational deterioration
- Return metrics critically weak: 0.7% ROE and 0.2% ROA demonstrate poor capital efficiency and value destruction
- Sustained losses with -24.4% operating and -28.5% net margins
- Negative interest coverage (-0.5x) suggests inability to service debt from operations
- High leverage (2.11x D/E) alongside -2.4% YoY revenue decline
Key Metrics to Watch
- Operating cash flow trend - must turn positive to restore financial health and dividend sustainability
- Debt maturity schedule and refinancing ability given negative cash generation
- Revenue stabilization and operating margin expansion required to improve interest coverage
- Cash position depletion rate given negative FCF
- Interest coverage
- Operating cash flow trend and sustainability
Medical Properties Trust Inc. (MPT) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
MPT Profit Margin, ROE & Profitability Analysis
MPT vs Real Estate Sector: How Medical Properties Trust Inc. Compares
How Medical Properties Trust Inc. compares to Real Estate sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Medical Properties Trust Inc. Stock Overvalued? MPT Valuation Analysis 2026
Based on fundamental analysis, Medical Properties Trust Inc. shows some fundamental concerns relative to the Real Estate sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Medical Properties Trust Inc. Balance Sheet: MPT Debt, Cash & Liquidity
MPT Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Medical Properties Trust Inc.'s revenue has declined by 36% over the 5-year period, indicating business contraction. The most recent EPS of $-0.93 indicates the company is currently unprofitable.
MPT Revenue Growth, EPS Growth & YoY Performance
MPT Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $223.8M | $32.8M | $0.05 |
| Q3 2025 | $225.8M | -$77.7M | $-0.13 |
| Q2 2025 | $240.4M | -$98.4M | $-0.16 |
| Q1 2025 | $223.8M | -$118.3M | $-0.20 |
| Q3 2024 | $225.8M | $107.5M | $0.18 |
| Q2 2024 | $266.6M | -$9.2M | $-0.02 |
| Q1 2024 | $271.3M | $32.8M | $0.05 |
| Q3 2023 | $306.6M | $107.5M | $0.18 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Medical Properties Trust Inc. Dividends, Buybacks & Capital Allocation
MPT SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Medical Properties Trust Inc. (CIK: 0001287865)
📋 Recent SEC Filings
❓ Frequently Asked Questions about MPT
What is the AI rating for MPT?
Medical Properties Trust Inc. (MPT) has a Combined AI Rating of STRONG SELL from Claude (STRONG SELL) and ChatGPT (STRONG SELL) with 81% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are MPT's key strengths?
Claude: Positive net income of $32.8M indicates some profitability despite operational headwinds. Substantial asset base of $14.8B provides collateral and restructuring options. ChatGPT: Positive operating cash flow and 23.7% FCF margin. Large asset base ($15.0B) with $4.61B equity.
What are the risks of investing in MPT?
Claude: Negative operating cash flow (-$14.3M) and negative free cash flow (-$14.3M) signal operational cash generation failure, critical for REIT viability. Interest coverage ratio of 0.0x means operating income cannot cover debt service; company depends on non-operating income or asset sales. ChatGPT: Sustained losses with -24.4% operating and -28.5% net margins. Negative interest coverage (-0.5x) suggests inability to service debt from operations.
What is MPT's revenue and growth?
Medical Properties Trust Inc. reported revenue of $252.1M.
Does MPT pay dividends?
Medical Properties Trust Inc. does not currently pay dividends.
Where can I find MPT SEC filings?
Official SEC filings for Medical Properties Trust Inc. (CIK: 0001287865) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is MPT's EPS?
Medical Properties Trust Inc. has a diluted EPS of $0.05.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is MPT a good stock to buy right now?
Based on our AI fundamental analysis in May 2026, Medical Properties Trust Inc. has a STRONG SELL rating with 81% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is MPT stock overvalued or undervalued?
Valuation metrics for MPT: ROE of 0.7% (sector avg: 8%), net margin of 13.0% (sector avg: 20%). Compare these metrics with sector averages to assess valuation.
Should I buy MPT stock in 2026?
Our dual AI analysis gives Medical Properties Trust Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is MPT's free cash flow?
Medical Properties Trust Inc.'s operating cash flow is $-14.3M, with capital expenditures of N/A. FCF margin is -5.7%.
How does MPT compare to other Real Estate stocks?
Vs Real Estate sector averages: Net margin 13.0% (avg: 20%), ROE 0.7% (avg: 8%), current ratio N/A (avg: 1.5).
Is Medical Properties Trust Inc. carrying too much debt?
MPT has a debt-to-equity ratio of 2.13x, which is above the Real Estate sector average of 1.5x. Combined with a current ratio below 1, this warrants careful monitoring of the balance sheet.